References
- Coiffier B, Hiddemann W, Stein H, et al. Mantle cell lymphoma: A therapeutic dilemma. Ann Oncol 1995; 6: 208–210
- Velders GA, Kluin-Nelemans JC, DeBoer CJ, et al. Mantle-cell lymphoma: A population-based clinical study. J Clin Oncol 1996; 14: 1269–1274
- Coiffier B. Which treatment for mantle-cell lymphoma patients in 1998?. J Clin Oncol 1998; 16: 3–5
- Meusers P, Engelhard M, Bartels H, et al. Multicenter randomized therapeutic trial for advanced centrocytic lymphoma: Anthracycline does not improve the prognosis. Hematol Oncol 1989; 7: 365–380
- Zucca E, Roggero E, Pinotti G, et al. Patterns of survival in mantle cell lymphoma. Ann Oncol 1995; 6: 257–262
- Fisher RI, Dahlberg S, Nathwani BN, et al. A clinical analysis of two indolent lymphoma entities: mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories): a Southwest Oncology Group study. Blood 1995; 85: 1075–1082
- Romaguera J, Khouri I, Kantarjian H, et al. HCVAD/MTX-Ara-C: A new effective regimen for diffuse and nodular mantle cell lymphoma (MCL). Blood 1996; 88(Suppl 1)121a
- Stewart DA, Vose JM, Weisenburger DD, et al. The role of high-dose therapy and autologous hematopoietic stem cell transplantation for mantle cell lymphoma. Ann Oncol 1995; 6: 263–266
- Ketterer N, Salles G, Espinouse D, et al. Intensive therapy with peripheral stem cell transplantation in 16 patients with mantle cell lymphoma. Ann Oncol 1997; 8: 701–704
- Freedman AS, Neuberg D, Gribben JG, et al. High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission. J Clin Oncol 1998; 16: 13–18